NCT00125853View on ClinicalTrials.gov

The Effect of Nebivolol on Insulin Sensitivity

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Hypertension
Interventions
DRUG

Nebivolol

Nebivolol 2.5mg daily

DRUG

Atenolol

Atenolol 25mg daily

Trial Locations (1)

W2 1PG

Imperial College London, Paddington

All Listed Sponsors
collaborator

Foundation for Circulatory Health

OTHER

lead

Imperial College London

OTHER

NCT00125853 - The Effect of Nebivolol on Insulin Sensitivity | Biotech Hunter | Biotech Hunter